Navigation Links
Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
Date:6/21/2013

New York, NY (PRWEB) June 21, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that a number of lawmakers are telling the Arkansas Supreme Court to uphold the $1.2 billion fine imposed on Johnson & Johnson (J&J) by a lower court for off-label marketing claims related to the company’s antipsychotic drug Risperdal, according to a June 18 Associated Press report published on WashingtonPost.com.

As noted in the report, state Attorney General Dustin McDaniel called on the state’s Supreme Court justices to reject J&J’s appeal of the lower court’s ruling in which the drug maker was found to have downplayed and hid risks associated with Risperdal use (State of Arkansas v. Ortho-McNeil-Janssen Pharmaceuticals Inc., case no: CV07-15345). Numerous supporters have emerged to back the lower court’s decision, including 35 state attorneys general, 65 Arkansas lawmakers, as well as former U.S. Food and Drug Administration (FDA) Commissioner Donald Kennedy, the report added.

The allegations that J&J had made off-label marketing claims centered on the company’s effort to prompt doctors to prescribe Risperdal for children before the FDA had approved the drug for use by children, according to an August 30, 2012, Reuters report. The FDA initially approved Risperdal for use by adults, in 1993; it wasn’t approved for children until 1997. As the Reuters article related, drug makers can only legally promote their drugs for FDA-approved uses. Doctors, on the other hand, are free to prescribe a drug for any reason they see fit – when it is for something not approved by the FDA, it is called using the drug “off-label.”

Risperdal is an antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and acute mania associated with autistic disorders. It has been linked to side effects such as male breast growth, known as gynecomastia. On April 1, 2006, the Journal of Clinical Psychopharmacology published a report releasing its findings that levels of prolactin – which is the hormone that stimulates milk production – are increased in Risperdal users. Parker Waichman LLP is offering free case evaluations for patients who took Risperdal and suffered from gynecomastia and other unexpected side effects. Symptoms of gynecomastia, as defined by the Mayo Clinic on its website, include:

  •     Swelling
  •     Pain
  •     Tenderness
  •     Nipple discharge in one or both breasts

Parker Waichman LLP continues to offer free lawsuit consultations to victims of Risperdal side effects. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's Risperdal Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636)

Contact: Parker Waichman LLP
                 Gary Falkowitz, Managing Attorney
                 (800) LAW-INFO
                 (800) 529-4636
                 http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/risperdal_arkansas_fine/06/prweb10859554.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. San Bruno, CA Dentist Dr. Bradley Parker Receives Top Reviews for New Laser Assisted Dental Treatments
2. YourPleasurableSecrets.com, a leading retailer of Pipedream Products, Adult Toys & Novelties, is replenishing their lineup of adult movies Kay Parker has starred in.
3. In Light of Alleged Deceptive Marketing Claims Made by Drug Makers, Parker Waichman LLP Addresses Issues Allegedly Related to the Safety and Effectiveness of Plavix
4. Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Responds to Doctor’s Testimony Alleging Intuitive Surgical’s Robotic Device Contributed to a Man’s Death
5. Wisconsin Woman Alleges She was Injured by Transvaginal Mesh Devices in Lawsuit Filed by Parker Waichman LLP
6. Parker Waichman LLP Files Class Action Lawsuit on Behalf of Consumers Who’ve Purchased Azek Decking
7. Texas Woman Alleges Actos Caused her Bladder Cancer, Parker Waichman LLP Files Lawsuit on Victim’s Behalf
8. In Light of New Research Findings, Parker Waichman LLP Warns about Risk of Texting While Driving
9. New York Woman Suffers Injuries Allegedly Due to Boston Scientific’s Transvaginal Mesh Device, Lawsuit Filed by Parker Waichman LLP
10. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
11. Parker Waichman LLP Responds to an Intuitive Surgical Notice that the da Vinci Surgical Robot, Due to a Defect, Can Electrically Burn a Patient During Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: